Global Gefitinib API Sales Market Report 2023

Report ID: 845719 | Published Date: Jan 2025 | No. of Page: 133 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story

It is a white powder with anti - tumor and anti - mitosis effect. The molecular formula is C22H24ClFN4O3, CAS number is 184475-35-2.

Market Analysis and Insights: Global Gefitinib API Market
The global Gefitinib API market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Gefitinib API Scope and Market Size
The global Gefitinib API market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gefitinib API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Purity ≥ 98 %
Purity ≥ 99 %

Segment by Application
Gefitinib Tablets
Other

The Gefitinib API market is analysed and market size information is provided by regions (countries). Segment by Application, the Gefitinib API market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Scion Pharm Taiwan
Farmhispania Group
Chem Genix
Jeil Pharmaceutical
Zhuhai Rundu Pharma
Cipla
Brawn Laboratories
Nischem International
Zhejiang Hisun Pharmaceutical
Qilu Pharmaceutial

Frequently Asked Questions
Gefitinib API report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Gefitinib API report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Gefitinib API report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Hydroxyurea API

It has the appearance of white crystal or crystal powder, which can resist tumor and inhibit mito ... Read More

Oxaliplatin API

The appearance is white or similar white powder, has the anti-tumor, the inhibition cell mitosis  ... Read More